Treatment with AAV-sFKN partially restored expression of both Ki67 and DCX in the SGZ, indicative of increased neurogenesis, suggesting that its ability to mitigate cognitive deficits in CX3CL1−/− mice could be dependent on this activity. This evidence concerns the gene DCX and Cognitive impairment.